From: Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
Arm A
Arm B
Total number of cycles
149
148
Median number of cycles (min-max)
3 (1–8)
3 (1–6)
No. of delayed cycles (%)
22 (14.8)
9 (6.1)
Median dose intensity
0.78
0.86